Abstract: The present invention is directed to novel substituted pyrazole compounds of Formula (I) or a form or composition thereof and the use thereof as inhibitors of ATP-protein kinase interactions.
Type:
Grant
Filed:
October 12, 2007
Date of Patent:
December 29, 2009
Assignee:
Janssen Pharmaceutica
Inventors:
George Chiu, Yang Yu, Ronghui Lin, Shengjian Li, Peter J. Connolly